THERAPEUTICALLY RESISTANT ASTHMA


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Therapy resistant asthma (TRA) is most difficult to treat and its course is least predictable. TRA remains least studied notwithstanding the fact that its many mechanisms have been detected. To this point there has been no clear definition of TRA and this terminology has not been widely used so far. This paper gives the results of an investigation, which could identify the phenotype of TRA, by taking into account its pathogenetic and clinical heterogeneity, reveal the predictors of the disease, and elaborate unique criteria to make its diagnosis.

全文:

受限制的访问

作者简介

V. Trofimov

Acad. I.P. Pavlov Saint Petersburg State Medical University

Email: trofvi@mail.ru

Zh. Mironova

Acad. I.P. Pavlov Saint Petersburg State Medical University

参考

  1. Gibeon, D., Campbell D., Debbie A. et al. The Systematic Assessment of Difficult-to-Treat Asthma: Why Do It? // Clinical Pulmonary Medicine. - 2010; 17 (6): 255-259.
  2. Федосеев Г.Б., Трофимов В.И., Петрова М. А. Многоликая бронхиальная астма, диагностика, лечение и профилактика. - М.: Нордмедиздат, 2011. - С. 343.
  3. Wenzel S. Severe Asthma in Adults // Am. J. Respir. Crit. Care Med. - 2005; 172: 149-160.
  4. Proceeding of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society // Am. J. Respir. Crit. Care Med.- 2000; 162: 2341-2351.
  5. Global Initiative for Asthma. Global strategy for asthma management and prevention. Workshop Report (электронный ресурс), 2008. Доступ: http://www. Ginaasthma.com.
  6. Ito K., Chung K., Adcock I. Update on glucocortucoid action and resistance // J. Allergy Clin. Immunol. - 2006; 3: 522-543.
  7. Newton R., Leigh R., Giembycz M. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung disease // Pharmacology & Therapeutics. - 2010; 125: 286-327.
  8. Трофимов В.И. Руководство по диагностике, лечению и профилактике бронхиальной астмы / под ред. А. Г. Чучалина. - М., 2005.
  9. Miller М., Lee J., Blanc P. et al. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma // Eur. Respir. J. - 2006; 28: 1145-1155.
  10. Mason R., Broaddus V., Martin T. et al. Murray & Nadel, s/Textbook of Respiratory medicine 5th edition V.1 Elsevier., 2010. - P. 883-918.
  11. Федосеев Г.Б., Трофимов В.И., Рогачева H.H. и др. Роль нейтрофилов и бактериальной инфекции респираторного тракта у больных бронхиальной астмой и хронической обструктивной болезнью легких // Росс. аллергологический журн. - 2011; 2: 34-43.
  12. Петровский В.Ф., Огородова Л.М. Выбор фармакотерапии тяжелой Б.А. // Пульмонология. - 2008; 3: 84-89.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##